Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02211235 · ClinicalTrials.gov registry record
Glycemic Monitoring in Cystic Fibrosis
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 146
- Enrollment target
NCT02211235: Completed study, sponsored by University of Colorado, Denver.
NCT02211235 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 146 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02211235 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 146 participants
- Enrollment target
Study Summary
Current guidelines on the diagnoses and management of cystic fibrosis (CF) related diabetes recommend treatment for diabetes based on diagnostic criteria derived from adults with type 2 diabetes. Increasing evidence supports treating early glucose abnormalities in cystic fibrosis patients to target CF specific outcomes, including lung function and nutrition (BMI-Body Mass Index). However, the criteria and timing of when to start insulin therapy in the 'prediabetic' state are unclear. A more accurate characterization of blood sugar variability in youth with and without CF will help the investigators better interpret continuous glucose monitor (CGM) findings in patients with CF prediabetes and diabetes and more accurately identify those individuals at greatest risk for disease progression.
Primary Outcome
Percentage of time above normal glucose cut-point.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2014-08 |
| Est. Completion | 2018-05-16 |
What the finished NCT02211235 record still lists
NCT02211235 is an observational study that tracks outcomes without assigning an intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02211235 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02211235 about?
NCT02211235 is a clinical study titled "Glycemic Monitoring in Cystic Fibrosis". Current guidelines on the diagnoses and management of cystic fibrosis (CF) related diabetes recommend treatment for diabetes based on diagnostic criteria derived from adults with type 2 diabetes. Increasing evidence supports treating early glucose abnormalities in cystic fibrosis patients to target ...
What is the current status of trial NCT02211235?
This trial is currently completed. The enrollment target is 146 participants. The study started on 2014-08. Estimated completion is 2018-05-16.
Who is sponsoring clinical trial NCT02211235?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia